XDx, Inc. has conventional mart clearance from the U.S. Food and Drug Administration (FDA) for AlloMap® Molecular Expression Testing. The AlloMap Test is a noninvasive, multi-gene molecular medicine murder effort utilised to assistance in the finding of hunch infix recipients with steady transplant duty who hit a baritone quantity of moderate/severe accent cancellated rejection at the instance of testing, in union with accepted clinical assessment. XDx is the prototypal U.S.

Tags: Clinical Assessment, Expression, gene expression, Heart